Disclosed positions

Estimated from their latest filings — positions may have changed since

$2.08M

combined est. value

Stock	Shares	Price	Value	Weight	As of
MDGLMADRIGAL PHARMACEUTICALS, INC.	2,627	$565.40	$1.49M	72%	2025-06-20
ACADACADIA PHARMACEUTICALS INC	12,148	$26.00	$315.8K	15%	2026-05-29
CYTKCYTOKINETICS INC	3,239	$84.88	$274.9K	13%	2026-05-27

MDGL

MADRIGAL PHARMACEUTICALS, INC.

$1.49M

2,627 sh

ACAD

ACADIA PHARMACEUTICALS INC

$315.8K

12,148 sh

CYTK

CYTOKINETICS INC

$274.9K

3,239 sh

All filings on record

Every Form 4 transaction we track for this filer

all 6buys 0sells 1

Stock	Transaction	Date	~6mo later
ACADACADIA PHARMACEUTICALS INC	Exercise — · 8,107 sh	2026-05-29	—
CYTKCYTOKINETICS INC	Grant — · 2,851 sh	2026-05-27	—
CYTKCYTOKINETICS INC	Grant $12.5K · 197 sh	2026-01-15	—
ACADACADIA PHARMACEUTICALS INC	Sell $671.0K · 30,000 sh	2025-11-10	—
MDGLMADRIGAL PHARMACEUTICALS, INC.	Grant — · 715 sh	2025-06-20	—
ACADACADIA PHARMACEUTICALS INC	Exercise — · 9,387 sh	2025-05-29	—

ACADExercise

2026-05-29 · ACADIA PHARMACEUTICALS INC

8,107

—

CYTKGrant

2026-05-27 · CYTOKINETICS INC

2,851

—

CYTKGrant

2026-01-15 · CYTOKINETICS INC

$12.5K

—

ACADSell

2025-11-10 · ACADIA PHARMACEUTICALS INC

$671.0K

—

MDGLGrant

2025-06-20 · MADRIGAL PHARMACEUTICALS, INC.

715

—

ACADExercise

2025-05-29 · ACADIA PHARMACEUTICALS INC

9,387

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.